Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6524]

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers 

$ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma$

ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or...

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

ASH 2025: Milder chemo works for rare, aggressive lymphoma

ASH 2025: Milder chemo works for rare, aggressive lymphoma

ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable

ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially...

Triaptosis - an emerging paradigm in cancer therapeutics

Triaptosis - an emerging paradigm in cancer therapeutics

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers

Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers

Telling women as part of mammography screening that they have dense breasts may have unintended effects

Telling women as part of mammography screening that they have dense breasts may have unintended effects

Lower doses of immunotherapy for skin cancer give better results

Lower doses of immunotherapy for skin cancer give better results

More from ecancer